Lupin launches Vilfuro-G for COPD Management in India
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
The Product will be manufactured at the company's facility in Bengaluru
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
Evinova will operate as a separate health-tech business within AstraZeneca
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) and is used in the treatment of seizures.
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Yesafili, received marketing authorization approval from the European Commission for the European Union
US business grew by +12.8% YoY
Subscribe To Our Newsletter & Stay Updated